MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2006-10-19
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 29
- Registration Number
- NCT00390000
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 1
Completed
- Conditions
- Anaplastic AstrocytomaRecurrent GlioblastomaAnaplastic OligodendrogliomaMixed Glioma
- Interventions
- Biological: Carcinoembryonic Antigen-Expressing Measles VirusOther: Laboratory Biomarker AnalysisProcedure: Therapeutic Conventional Surgery
- First Posted Date
- 2006-10-19
- Last Posted Date
- 2020-01-02
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 23
- Registration Number
- NCT00390299
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Alpha Lipoic Acid for Burning Mouth
Completed
- Conditions
- Burning Sore Mouth
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2011-04-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 200
- Registration Number
- NCT00387543
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Diabetes Medication Choice
Not Applicable
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Behavioral: Usual CareBehavioral: Diabetes Medication Choice decision aid
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2015-04-28
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 85
- Registration Number
- NCT00388050
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor
Phase 1
Terminated
- Conditions
- Cardiopulmonary Bypass
- Interventions
- Drug: Nelfinavir/placebo
- First Posted Date
- 2006-10-09
- Last Posted Date
- 2015-04-28
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 41
- Registration Number
- NCT00385450
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Azacitidine in Treating Patients With Myelofibrosis
Phase 2
Terminated
- Conditions
- Chronic Myeloproliferative DisordersSecondary Myelofibrosis
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2011-04-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT00381693
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones
Phase 1
Completed
- Conditions
- CystinuriaNephrolithiasis, Calcium Oxalate
- Interventions
- Drug: CystoneDrug: Sugar Pill (Placebo)
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2016-02-04
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT00381849
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Intervention for Support Persons to Help Smokers Quit
Phase 1
Completed
- Conditions
- Smoking Cessation
- First Posted Date
- 2006-09-21
- Last Posted Date
- 2010-11-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 70
- Registration Number
- NCT00379054
- Locations
- 🇺🇸
Mayo, Rochester, Minnesota, United States
Tobacco Cessation Treatment for Pregnant Alaska Natives
Phase 1
Completed
- Conditions
- Tobacco Use
- First Posted Date
- 2006-09-21
- Last Posted Date
- 2012-03-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 35
- Registration Number
- NCT00379444
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Incretins in Impaired Fasting Glucose
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2011-12-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 22
- Registration Number
- NCT00364377
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath